Rhythm Pharmaceuticals, Inc. financial statements
Rhythm Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 189.76M | 10-K |
| Net income | −USD 196.54M | 10-K |
| Cash and equivalents | USD 54.3M | 10-Q |
| Total debt | USD 108.18M | 10-Q |
Rhythm Pharmaceuticals, Inc. financials on 6ix · Rhythm Pharmaceuticals, Inc. on 6ix